October 2018
- Specialist neonatal respiratory care for babies born preterm
- Needle size for vaccination procedures in children and adolescents
- Glucocorticoids for croup in children
- Improving children and young people’s mental health services
- Transdermal fentanyl patches: life-threatening and fatal opioid toxicity from accidental exposure, particularly in children
- Improving children and young people’s mental health services
- Does melatonin improve sleep in children with neurodevelopmental disorders?
- Lipid‐based nutrient supplements for maternal, birth, and infant developmental outcomes
- Burosumab for treating X-linked hypophosphataemia in children and young people – guidance (HST8)
- Coeliac disease in children
- Different infusion durations for preventing platinum‐induced hearing loss in children with cancer
September 2018
- Boosting the development of medicines for children
- Poor Metabolic Control in Children and Adolescents With Type 1 Diabetes and Psychiatric Comorbidity
- Positive Phase II data for once-weekly growth hormone analogue (somapacitan) in childhood growth hormone deficiency
- Meningitis report: Spotting a seriously ill child
- Ketorolac for postoperative pain in children
- September BNF/BNFC eNewsletter
- Medical and surgical interventions for the treatment of urinary stones in children
- Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial
- Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
- Long-term developmental effects of withholding parenteral nutrition for 1 week in the paediatric intensive care unit: a 2-year follow-up of the PEPaNIC international, randomised, controlled trial
- Long-Term Risk of Venous Thromboembolism in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
- Impact of antibiotics for children presenting to general practice with cough on adverse outcomes: secondary analysis from a multicentre prospective cohort study
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
- Bronchiectasis in children: diagnosis and treatment
- Tisagenlecleucel to be made available on NHS for children and adults up to age 25 years for B cell acute lymphoblastic leukaemia
- Burosumab for treating X-linked hypophosphataemia in children and young people – Final appraisal determination
- The Good Childhood Report 2018
- Treatment of extravasation injuries in infants and young children: a scoping review and survey
- An overview of the EU’s orphan designation programme
- Face‐to‐face interventions for informing or educating parents about early childhood vaccination
- Clonazepam add‐on therapy for refractory epilepsy in adults and children
- Revised SPC: Blincyto (blinatumomab) solution
August 2018
- Mepolizumab approved in EU for treatment of paediatric patients with severe eosinophilic asthma
- Paracetamol (acetaminophen) for patent ductus arteriosus (a blood vessel necessary for fetal survival) in preterm and low birth weight infants
- Interventions for infantile haemangiomas of the skin
- Honey for acute cough in children
- BNF and BNF for Children Update: August 2018
- Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children
- National Paediatric Diabetes Audit
- Perinatal Marijuana Use and the Developing Child
- Paediatric intensive care and neonatal intensive care airway management in the United Kingdom: the PIC‐NIC survey
- Video on valproate use during pregnancy to support healthcare professionals
- The Risk of Offspring Psychiatric Disorders in the Setting of Maternal Obesity and Diabetes
- Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
- Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study
- Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth
- FDA approve lumacaftor/ivacaftor (Orkambi) Cystic Fibrosis for Children Ages 2-5 Years in US
- Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: A total population register-linkage study
- Effect of a Responsive Parenting Educational Intervention on Childhood Weight Outcomes at 3 Years of Age: The INSIGHT Randomized Clinical Trial
- NIHR Signal Adding emollients to the bath unlikely to help children with eczema
- Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
- Revised SPC: Rotarix (Human rotavirus, RIX4414 strain, live, attenuated) Oral Applicator
- Revised SPC: Briviact (brivaracetam) 10 mg/ml oral solution – licensed from 4 years of age
- Safety and Side Effects of Rifampin versus Isoniazid in Children
July 2018
- Association Between the New York Sepsis Care Mandate and In-Hospital Mortality for Pediatric Sepsis
- BNF and BNFC Update: July 2018
- Revised SPC: Gentamicin Intrathecal 5mg/ml – no longer contra-indicated in under one year of age
- Clarification of the doses at extremes of body-weight statement for vancomycin in BNF and BNF for Children
- Antidepressant prescriptions for children on the rise
- In use product safety assessment report for intravenous paracetamol in paediatrics
- Scientific Advisory Committee on Nutrition (SACN) publishes report on ‘Feeding in the first year of life’
- Perinatal Marijuana Use and the Developing Child
- Recurrent lower respiratory tract infections in children
- Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden
June 2018
- NIHR Signal: Oral ibuprofen may be an option for closing patent ductus arteriosus in premature babies
- Xenidate XL (methylphenidate) Prolonged-release Tablets: Checklist before prescribing
- MHRA will continue to monitor safety of opioid patches after baby’s death
- European CHMP recommends approval of tisagenlecleucel (Kymriah) for acute lymphoblastic leukaemia (ALL) and diffuse large B cell lymphoma (DLBCL)
- Revised SPC: Curosurf (poractant alfa)
- Public Health England and Disney UK launch Change4Life Train Like A Jedi programme
- June BNF/BNFC eNewsletter
- Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
- Perceptions of future health and cancer risk in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
- Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study
- UK to review medical cannabis policy
- Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies
- The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
- Idiopathic nephrotic syndrome in children
- Burosumab for treating X-linked hypophosphataemia in children and young people: Evaluation consultation
- Spiriva (tiotropium) Respimat licensed in UK for treatment of asthma in patients aged six years and above
- Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial
- Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
- At-risk children with asthma (ARC): a systematic review
- European CHMP recommends approval of adalimumab biosimilars (Halimatoz, Hefiya and Hyrimoz)
- European CHMP recommends approval of nitisinone (Nityr) for treatment of hereditary tyrosinemia type 1
May 2018
- Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review
- Association Between Vitamin D Supplementation During Pregnancy and Offspring Growth, Morbidity, and Mortality – A Systematic Review and Meta-analysis
- Mass chemoprophylaxis for control of outbreaks of meningococcal disease
- Adolescent affective symptoms and mortality
- Higher versus lower amino acid intake in parenteral nutrition for newborn infants
- Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants
- Important considerations for interpreting biochemical tests in children
- US FDA accepts supplemental biologics license application for prophylactic and paediatric use of Coagadex® (Coagulation Factor X, Human) for treatment of hereditary factor X deficiency
- Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants
- Immunoglobulin for alloimmune hemolytic disease in neonates
- European Medicines Agency investigating new study suggesting increased risk of neural tube defects in infants born to women who took dolutegravir at conception
- Systemic corticosteroids for acute otitis media in children
- Developmental follow-up of children and young people born preterm – quality standard (QS169)
- Cystic fibrosis – quality standard (QS168)
- Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease
- The use of complementary and alternative medicines during breastfeeding: results from the Herbal supplements in Breastfeeding InvesTigation (HaBIT)
- US FDA approves oral brivaracetam for the treatment of partial-onset (focal) seizures in paediatric patients
- Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes
- Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates
- FDA expands approval of fingolimod (Gilenya) to treat multiple sclerosis in paediatric patients
- Which weak opioids can be used during breastfeeding? Considering the evidence for codeine, dihydrocodeine, and tramadol
- Prevalence estimates and risk factors for early childhood wheeze across Europe: the EuroPrevall birth cohort
- Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor
- Which oral antihistamines are safe to use whilst breastfeeding?
- Vaccines for preventing influenza in healthy children
- Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis
- NIHR Signal: Domperidone increases breast milk production in mothers of premature babies
- Can mothers breastfeed after a medical termination of pregnancy?
- Breastfeeding and lithium: is breast always best?
- Inhaled mannitol for cystic fibrosis
- Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness
- Early antiretroviral therapy in HIV-infected infants: can it lead to HIV remission?
- Effect of Atropine With Propofol vs Atropine With Atracurium and Sufentanil on Oxygen Desaturation in Neonates Requiring Nonemergency Intubation: A Randomized Clinical Trial
- Extended-release methylphenidate – An updated review of the pharmacokinetic profiles of available preparations
- Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions
For older news click here